OCS: Oculis Holding AG Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 821.28
Enterprise Value ($M) n/a
Book Value ($M) 95.23
Book Value / Share 2.27
Price / Book n/a
NCAV ($M) 81.11
NCAV / Share 1.93
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.72
Return on Assets (ROA) -0.61
Return on Equity (ROE) -0.74

Liquidity (mrq)
Quick Ratio 4.02
Current Ratio 4.02

Balance Sheet (mrq) ($M)
Current Assets 111.49
Assets 125.61
Liabilities 30.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-12 13G/A LSP 7 Cooperative UA 13.80 7.99
02-11 13G/A Bvcf Iv, L.p. 5.05 5.88
01-03 13G/A Brunnur vaxtarsjodur slhf 0.00 -100.00
12-09 13G Pivotal bioVenture Partners Fund I, L.P. 5.20 6.98
2024-02-13 13G/A Novartis Bioventures Ltd 4.70 -21.32

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-03 3,011 34,552 8.71
2025-02-28 3,748 37,344 10.04
2025-02-27 5,873 51,663 11.37
2025-02-26 2,835 40,760 6.96

(click for more detail)

Similar Companies
NKGN – NKGen Biotech, Inc. NRIX – Nurix Therapeutics, Inc.
NTLA – Intellia Therapeutics, Inc. OCUL – Ocular Therapeutix, Inc.
OKUR – OnKure Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io